Collagen-induced arthritis in C57BL/6 (H-2b) mice: New insights into an important disease model of rheumatoid arthritis

European Journal of Immunology

Volumn 30, Issue 6, 2000, Pages 1568-1575

  Campbell, Ian K ^a,b,c   Hamilton, John A ^a,b,c   Wicks, Lan P ^a,b,c  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Autoimmunity; In vivo animal model; Knockout; MHC; Rheumatoid arthritis; Transgenic

Indexed keywords

CD4 ANTIGEN; COLLAGEN; COLLAGEN TYPE 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE RESISTANCE; DISEASE SEVERITY; HAPLOTYPE; HISTOLOGY; IMMUNIZATION; INCIDENCE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; STEM CELL; T LYMPHOCYTE;

ANIMALS; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; COLLAGEN; DISEASE MODELS, ANIMAL; H-2 ANTIGENS; INCIDENCE; KINETICS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; T-LYMPHOCYTES;

EID: 0034081170     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R     Document Type: Article

References (34)

1. Myers, L. K., Rosloniec, E. F., Cremer, M. A. and Kang, A. H., Collagen-induced arthritis, an animal model of autoimmunity. Life Sei. 1997.61:1861-1878.
2. Wooley, P. H., Dillon, A. M.( Luthra, H. S., Stuart, J. M. and David, C. S., Genetic control of type II collagen-induced arthritis in mice: factors influencing disease susceptibility and evidence for multiple MHC-associated gene control. Transplant. Proc. 1983.15:180-185.
3. Zanelli, E., Gonzalez-Gay, M. A. and David, C. S., Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol. Today 1995.16:274-278.
4. Andersson, E. C., Hansen, B. E., Jacobsen, H., Madsen, L. S., Andersen, C. B., Engberg, J., Rothbard, J. B., McDevitt, G. S., Malmström, V., Holmdahl, R., Svejgaard, A. and Fugger, L., Définition of MHC and T cell receptor contacts in the HLA-DR4-restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc. Natl. Acad. Sei. USA 1998. 95: 7574-7579.
5. Mori, L., Iselin, S., De Libero, G. and Lesslauer, W., Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-lgG1-treated and TNFR1-deficient mice. J. Immunol. 1996. 157:3178-3182.
6. Alonzi, T., Fattori, E., Lazzaro, D., Costa, P., Probert, L., Kollias, G., de Benedetti, F., Poli, V. and Ciliberto, G., Interleukin 6 is required for the development of collagen-induced arthritis. J. Exp. Med. 1998.187:461-468.
7. Wooley, P. H., Collagen-induced arthritis in the mouse. Methods Enzymol. 1988.162: 361-373.
8. Knight, B., Katz, D. R., Isenberg, D. A., Ibrahim, M. A., Le Page, S., Hutchings, P., Schwartz, R. S. and Cooke, A., Induction of adjuvant arthritis in mice. Clin. Exp. Immunol. 1992. 90: 459-465.
9. Yoshino, S., Murata, Y. and Ohsawa, M., Successful induction of adjuvant arthritis in mice by treatment with a monoclonal antibody against IL-4. J. Immunol. 1998.161: 6904-6908.
10. Campbell, I. K., Bendele, A., Smith, D. A. and Hamilton, J. A., Granulocyte-macrophage colony stimulating factor exacerbates collagen induced arthritis in mice. Ann. Rheum. Dis. 1997. 56: 364-368.
11. Seki, N., Sudo, Y., Yoshïoka, T., Sugihara, S., Fujitsu, T., Sakuma, S., Ogawa, T., Hamaoka, T., Senoh, H. and Fujiwara, H., Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cellmediated immunity. J. Immunol. 1988.140:1477-1484.
12. d) mice. Eur. J. Immunol. 1995. 25: 763-769.
13. Martin, R. M., Bradie, J. L. and Lew, A. M., The need for lgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J. Immunol. Methods 1998.212:187-192.
14. Holmdahl, R., Jansson, L., Andersson, M. and Larsson, E., Immunogenetics of type II collagen autoimmunity and susceptibility to collagen arthritis. Immunology 1988. 65:305-310.
15. Courtenay, J. S., Dallman, M. J., Dayan, A. D., Martin, A. and Mosedale, B., Immunisation against heterologous type II collagen induces arthritis in mice. Nature 1980. 283: 666-668.
16. Caccese, R. G., Zimmerman, J. L. and Carison, R. P., Bacterial lipopolysaccharide potentiates type II collagen-induced arthritis in mice. Mediators Inflam. 1992.1: 273-279.
17. Joosten, L. A. B., Helsen, M. M. A. and van den Berg, W. B., Accelerated onset of collagen-induced arthritis by remote inflammation. Clin. Exp. Immunol. 1994. 97: 204-211.
18. Kalo, F., Nomura, M. and Nakamura, K., Arthritis in mice induced by a single immunisation with collagen. Ann. Rheum. Dis. 1996.55:535-539.
19. Hess, H., Gately, M. K., Rüde, E., Schmitt, E., Szeliga, J. and Germann, T., High doses of interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund's adjuvant. Eur. J. Immunol. 1996. 26: 187-191.
20. Watson, W. C. and Townes, A., Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the lgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci. J. Exp. Med. 1985.162:1878-1891.
21. Svensson, L, Jirholt, J., Holmdahl, R. and Jansson, L., B celldeficient mice do not develop type II collagen-induced arthritis. Clin. Exp. Immunol. 1998.111: 521-526.
22. Michaëlsson, E., Holmdahl, M., Engström, A., Burkhardt, H., Scheynius, A. and Holmdahl, R., Macrophages, but not dendritic cells, present collagen to T cells. Eur. J. Immunol. 1995. 25: 2234-2241.
23. Ranges, G. E., Sriram, S. and Cooper, S. M., Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J. Exp. Med. 1985.162:1105-1110.
24. Gonzalez-Gay, M. A., Zanelli, E., Khare, S. D., Krco, C. J., Griffiths, M. M., Luthra, H. S. and David, C. S., H2-A polymorphism contributes to H2-E-mediated protection in collagen-induced arthritis. Immunogenetics 1996. 44: 377-384.
25. Mathis, 0. J., Benoist, C., Williams, V. E., II, Kanter, M. and McDevitt, H. O., Several mechanisms can account for defective £ gene expression in different mouse haplotypes. Proc. Natl. Acad. Sei. USA 1983. 80: 273-277.
26. Taneja, V., Hansen, J., Smart, M., Griffiths, M., Luthra, H. and David, C. S., Expression of the H2-E molecule mediates protection to collagen-induced arthritis in HLA-DQ8 transgenic mice: role of cytokines. Int. Immunol. 1997. 9:1213-1219.
27. Thomson, W., Harrison, B., Oilier, B., Wiles, N., Payton, T., Barrett, J., Symmons, D. and Silman, A., Quantifying the exact role of HLA-DRB1 alleles in susceptibility to inflammatory polyarthritis. Arthritis Rheum. 1999. 42: 757-762.
28. Jirholt, J., Cook, A., Emahazion, T., Sundvall, M., Jansson, L., Nordquist, N., Pettersson, U. and Holmdahl, R., Genetic linkage analysis of collagen-induced arthritis in the mouse. Eur. J. Immunol. 1998. 28: 3321-3328.
29. Mori, L. and de Libero, G., Genetic control of susceptibility to collagen-induced arthritis in T cell receptor β-chain transgenic mice. Arthritis Rheum. 1998. 41: 256-262.
30. Slavin, A., Ewing, C., Liu, J., Ichikawa, M., Slavin, J. and Bernard, C. C. A., Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. Autoimmunity 1998. 28:109-120.
31. Gonzalez, A., Katz, J. D., Mattel, M.-G., Kikutani, H., Benoist, C. and Mathis, D., Genetic control of diabetes progression. Immunity 1997. 7:873-883.
32. Königen, F., Süss, G., Stewart, C., Steinmetz, M. and Bluethmann, H., Targeted disruption of the MHC class II Aa gene in C57BL76 mice. Int. Immunol. 1993. 5:957-964.
33. Campbell, I. K., Rich, M. J., Bischof, R. J., Dünn, A. R., Grail, D. and Hamilton, J. A., Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factordeficient mice. J. Immunol. 1998.161: 3639-3644.
34. Mandel, T. E. and Koulmandra, M., Fetal pig pancreas xenografts in non-obese diabetic mice treated with continuous antiCD4 monoclonal antibody. Transplant. Proc. 1991. 23: 583-584.